Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy.
作者信息
Hiwase D K, White D, Zrim S, Saunders V, Melo J V, Hughes T P
出版信息
Leukemia. 2010 Mar;24(3):658-60. doi: 10.1038/leu.2009.242. Epub 2009 Dec 10.
PMID:20010623
Abstract
摘要
Zotero 插件